FindTrial
Sign In

25-Hydroxyvitamin D Levels and the Risk of Stroke

25-Hydroxyvitamin D Levels and the Risk of cerebrovascular disease:A Prospective Study and Meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002333
Enrollment
Unknown
Registered
2012-07-07
Start date
2011-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Cerebral thrombosis group:NA
Lacunar infarction group:NA
Health Group:NA

Sponsors

Affiliated hospital of Beihua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 50-80 years; 2. Imaging(CT or MRI)confirms cerebral thrombosis or lacunar infarction; 3. Age matched healthy individual.

Exclusion criteria

Exclusion criteria: 1. Patients with cerebral hemorrhage; 2. Patients with cerebral transient ischemic attack(TIA); 3. Patients with cerebral tumour, cerebral trauma, or cerebral embolism; 4. Patients with serious hepatic, renal, orhematological, endocrine disease,osteoarthrosis or psychotic diseases; 5. Patients that are taking part in other clinical trials.

Design outcomes

Primary

MeasureTime frame
25-Hydroxyvitamin D;—

Contacts

Public ContactYuqi Zhang
mengbsh91@163.com+86 13843276177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026